Trial intelligence / Profile preview

Vitamin D in Acute Coronary Syndrome

NCT01115842Phase 4Unknown

Sponsor
Meir Medical Center
Start
Jun 2010
Primary completion
Dec 2010
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, open-label trial of vitamin d in acute coronary syndrome (ACS) (2 arms), sponsored by Meir Medical Center. Primary endpoint: Levels of immune mediating cytokines at 5 days. Status: unknown.

02

Drugs

vitamin d
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT01115842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01115842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call